A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

HeartStation Selects iBASIS eSIM for Remote Monitoring of AEDs to Ensure They Are Fully Powered and Operational in the Event of an Emergency

What To Know

  • The iBASIS solution is differentiated in its ability to enable dynamic routing selection of communications carrier in the cloud to drive the most effective network connectivity to remotely monitor and manage devices worldwide.
  • Today iBASIS, a provider of communications solutions for operators and digital players worldwide, announced that HeartStation, a global manufacturer of Automated External Defibrillator (AED) cabinets and accessibility products, has selected iBASIS eSIM for remote monitoring of AEDs to ensure they are fully powered and operational in the event of an emergency.

Today iBASIS, a provider of communications solutions for operators and digital players worldwide, announced that HeartStation, a global manufacturer of Automated External Defibrillator (AED) cabinets and accessibility products, has selected iBASIS eSIM for remote monitoring of AEDs to ensure they are fully powered and operational in the event of an emergency.

iBASIS’ selection follows one of the fastest implementations of its IoT solution to date, with field trials completed in just five days in late December 2019 and solution installed as of January 2020.

As the U.S. National Safety Council reports, greater access to AEDs could save 40,000 lives each year in the U.S. alone, and access to fully powered AEDs by bystanders can increase the odds of survival up to 40% and higher.1 The iBASIS eSIM enables dynamic monitoring of AEDs via an eSIM card installed within the AED cabinet. A signal is regularly monitored during the AED self-test, with automatic alerts to dispatch a technician should the device not meet the necessary operation.

Over 50,000 HeartStation AED units will be globally, remotely monitored via the iBASIS eSIM. The iBASIS solution is differentiated in its ability to enable dynamic routing selection of communications carrier in the cloud to drive the most effective network connectivity to remotely monitor and manage devices worldwide.

“The iBASIS eSIM is the perfect solution to further enhance the effectiveness of critical public access defibrillation programs by enabling remote monitoring of AEDs,” says Keith Hochhalter, President, HeartStation. “This solution ensures that devices will be fully available in critical circumstances, and we are very proud to partner with a company that shares our commitment to delivering life-changing innovation and performance.”

“HeartStation has developed unsurpassed capabilities for enhancing access to lifesaving devices,” says Ajay CTO, iBASIS. “We are extremely pleased to partner with them to deliver the remote monitoring needed to ensure their devices are always powered. We are also very happy with the incredible speed with which the teams have implemented the iBASIS eSIM capability. Our work with HeartStation reflects our commitment to enabling companies around the world to rapidly achieve the highest performance in management and monitoring of their products globally.”


Reference

1 Source: US National Safety Council

SourceiBASIS
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The study is designed to assess the clinical utility and workflow benefits of Swoop® system images acquired at infusion centers and clinics to help physicians detect amyloid-related imaging abnormalities (ARIA) in Alzheimer’s patients receiving amyloid-targeting therapy at the times specified in the labeling (before the fifth, seventh, and fourteenth infusions).
“Tom and I have more than 50 years of experience,” Harp adds. “The decision to found Polymer Medical was done after careful consideration of the landscape and market opportunity; we will raise the level of competition and quality for customers.” Polymer Medical is located in a newly refurbished plant is at 168 Thorn Ave., Orchard Park, N.Y.
The RWE Program will expand Summus Laser's Class IV Laser Therapy research to generate validated and statistically significant datasets that will be used to enhance patient care, outcomes, and to further product innovations.
Details of the session: Polaroid Therapeutics & Avery Dennison Medical: How the power of partnership brings a novel approach to antimicrobial wound dressings.
SABIC advises the project was initiated together with the dialysis department at Jessa Hospital, one of the largest non-university medical cluster in the Limburg region of Flanders, Belgium.

By using this website you agree to accept Medical Device News Magazine Privacy Policy